Direct Regulation of the T Cell Antigen Receptor's Activity by Cholesterol
- PMID: 33490080
- PMCID: PMC7820176
- DOI: 10.3389/fcell.2020.615996
Direct Regulation of the T Cell Antigen Receptor's Activity by Cholesterol
Abstract
Biological membranes consist of hundreds of different lipids that together with the embedded transmembrane (TM) proteins organize themselves into small nanodomains. In addition to this function of lipids, TM regions of proteins bind to lipids in a very specific manner, but the function of these TM region-lipid interactions is mostly unknown. In this review, we focus on the role of plasma membrane cholesterol, which directly binds to the αβ T cell antigen receptor (TCR), and has at least two opposing functions in αβ TCR activation. On the one hand, cholesterol binding to the TM domain of the TCRβ subunit keeps the TCR in an inactive, non-signaling conformation by stabilizing this conformation. This assures that the αβ T cell remains quiescent in the absence of antigenic peptide-MHC (the TCR's ligand) and decreases the sensitivity of the T cell toward stimulation. On the other hand, cholesterol binding to TCRβ leads to an increased formation of TCR nanoclusters, increasing the avidity of the TCRs toward the antigen, thus increasing the sensitivity of the αβ T cell. In mouse models, pharmacological increase of the cholesterol concentration in T cells caused an increase in TCR clustering, and thereby enhanced anti-tumor responses. In contrast, the γδ TCR does not bind to cholesterol and might be regulated in a different manner. The goal of this review is to put these seemingly controversial findings on the impact of cholesterol on the αβ TCR into perspective.
Keywords: T cell; TCR; allostery; cholesterol; lipid; nanocluster; signaling.
Copyright © 2021 Pathan-Chhatbar, Drechsler, Richter, Morath, Wu, OuYang, Xu and Schamel.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
The Allostery Model of TCR Regulation.J Immunol. 2017 Jan 1;198(1):47-52. doi: 10.4049/jimmunol.1601661. J Immunol. 2017. PMID: 27994168 Review.
-
Cholesterol Binds in a Reversed Orientation to TCRβ-TM in Which Its OH Group is Localized to the Center of the Lipid Bilayer.J Mol Biol. 2021 Dec 3;433(24):167328. doi: 10.1016/j.jmb.2021.167328. Epub 2021 Oct 22. J Mol Biol. 2021. PMID: 34688686
-
Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen.Proteins. 2020 Mar;88(3):503-513. doi: 10.1002/prot.25829. Epub 2019 Oct 21. Proteins. 2020. PMID: 31589793 Free PMC article.
-
A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation.Immunity. 2016 May 17;44(5):1091-101. doi: 10.1016/j.immuni.2016.04.011. Immunity. 2016. PMID: 27192576
-
αβ and γδ T cell receptors: Similar but different.J Leukoc Biol. 2020 Jun;107(6):1045-1055. doi: 10.1002/JLB.2MR1219-233R. Epub 2020 Jan 29. J Leukoc Biol. 2020. PMID: 31994778 Review.
Cited by
-
Evaluating immunotherapeutic outcomes in triple-negative breast cancer with a cholesterol radiotracer in mice.JCI Insight. 2024 Mar 19;9(8):e175320. doi: 10.1172/jci.insight.175320. JCI Insight. 2024. PMID: 38502228 Free PMC article.
-
Cholesterol Sulfate: Pathophysiological Implications and Potential Therapeutics.Biomolecules. 2025 Apr 30;15(5):646. doi: 10.3390/biom15050646. Biomolecules. 2025. PMID: 40427539 Free PMC article. Review.
-
Decoding the crosstalk between mevalonate metabolism and T cell function.Immunol Rev. 2023 Aug;317(1):71-94. doi: 10.1111/imr.13200. Epub 2023 Mar 31. Immunol Rev. 2023. PMID: 36999733 Free PMC article. Review.
-
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.Oncologist. 2024 Mar 4;29(3):e372-e381. doi: 10.1093/oncolo/oyad273. Oncologist. 2024. PMID: 37796838 Free PMC article.
-
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance.Front Oncol. 2025 Mar 18;15:1549237. doi: 10.3389/fonc.2025.1549237. eCollection 2025. Front Oncol. 2025. PMID: 40171265 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials